Kamil Ali-Jackson | Chief Legal Officer |
Neal Walker | President and Chief Executive Officer |
David Gordon | Chief Medical Officer |
Frank Ruffo | Chief Financial Officer |
Jeff Wayne | Interim Head of Commercial |
Louise Chen | Cantor |
Liav Abraham | Citi |
Donald Ellis | JMP Securities |
Tim Lugo | William Blair |
Good day, ladies and gentlemen, and welcome to the Q2 2019 Aclaris Therapeutics, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, we will host a question-and-answer session and our instructions will be given at that time. [Operator Instructions] As a reminder, this conference call may be recorded.